Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› L’Aquila
Clinical trial register · Italy

Clinical Trials in L’Aquila, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of L'Aquila5 AbbVie4 Incyte Corporation2 Sanofi2 Pfizer2
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in L’Aquila

33 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
University Hospital of Ferrara
Not applicable
1,612
Andria, Arezzo, Bologna, Ferrara, Grosseto, L’Aquila, Mirano, Ravenna
2026-05-25
Not yet open
Standardized Italian netwoRk Enrolling iNdividuals With Islet-Autoantibodies
NCT07503366Type 1 Diabetes (T1D), Autoantibodies, Hyperglycemia, Impaired Glucose Tolerance (Prediabetes)
Società Italiana di Endocrinologia e Diabetologia Pediatrica
Observational
300
Ancona, Bari, Bolzano, Caserta, Catanzaro, Crotone, Florence, L’Aquila
2026-05
Not yet open
CardioLogical Interventions and Acute strOke Treatment sTudy
NCT07314476Acute Ischemic Stroke AIS, Stroke Treatment, PCI Patients, Aortic Valve Replacement
University of L'Aquila
Observational
400
L’Aquila
2026-01
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Ancona, Cittadella, Lecco, L’Aquila, Messina, Milan, Naples, Novara
2025-09-22
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
L’Aquila, Cagliari, Rozzano, Baggiovara, Bologna, Chieti, Naples, Roma
2025-09-22
Recruiting
AbbVie
Observational
700
L’Aquila, Milan, Naples, Rome, Genova
2025-09-09
Recruiting
Amgen
Phase 3
12,800
Arzignano, Caserta, Ceccano, Chieti, Foggia, L’Aquila, Milan, Padova
2025-07-25
Recruiting
Incyte Corporation
Phase 3
600
Bari, Brescia, Catania, Chieti, Florence, L’Aquila, Milan, Naples
2025-02-28
Recruiting
Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants
NCT06823466Ischemic Stroke, Oral Anticoagulation, Atrial Fibrillation (AF), Outcome Assessment
University of L'Aquila
Observational
200
Ancona, Bari, Bologna, Città di Castello, Ferrara, Florence, Frosinone, L’Aquila
2025-02-12
Not yet open
Point-of-care Low-field MRI in Acute Stroke
NCT05816213Stroke, Ischemic Stroke, Hemorrhagic Stroke, Magnetic Resonance Imaging
University of L'Aquila
Observational
300
Avezzano, Chieti, L’Aquila, Milan
2025-02-01
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Not applicable
200
Milan, L’Aquila
2025-01-27
Recruiting
Novo Nordisk A/S
Phase 2
465
L’Aquila, Chieti, Bologna, Bergamo, Brescia, Milan, Pisa, Roma
2024-12-02
Recruiting
Francesca Pistoia
Not applicable
100
L’Aquila
2024-12
Active, closed
Pfizer
Phase 3
200
L’Aquila, Bari, Milan, Rome, Brescia, Latina, Pavia, Roma
2024-11-15
Recruiting
Adjunctive Effect of Erythritol on Pocket Closure Rates
NCT06958874Periodontitis, Pocket, Periodontal, Pocket, Gingival
University of L'Aquila
Not applicable
56
L’Aquila
2024-11-08
By invitation
Powered vs. Manual Toothbrushing in Stage 3-4 Periodontitis
NCT06980714Periodontitis, Dental Plaque, Gingival Bleeding
University of L'Aquila
Not applicable
50
L’Aquila
2024-11-01
Active, closed
Incyte Corporation
Phase 3
349
Catania, Chieti, L’Aquila, Milan, Naples, Perugia, Pisa, Rome
2024-10-10
Active, closed
Novartis Pharmaceuticals
Observational
379
Ancona, L’Aquila, Bari, Bergamo, Chieti, Catania, Catanzaro, Cona
2024-07-30
Recruiting
AbbVie
Phase 3
200
L’Aquila, Rozzano, Rome, Milan
2024-06-14
Active, closed
Sanofi
Phase 3
1,541
Milan, Rozzano, Rome, Bologna, Catania, L’Aquila, Pisa, Vicenza
2024-05-08
Recruiting
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
NCT07159750Migraine, Episodic Migraine, Chronic Migraine, Headache
Hospital Universitari Vall d'Hebron Research Institute
Observational
700
L’Aquila, Modena, Pavia, Roma
2024-01-02
Active, closed
Pfizer
Phase 3
1,571
L’Aquila, Florence, Milan, Roma, Rome, Cagliari
2023-11-08
Recruiting
AbbVie
Phase 3
1,500
Florence, L’Aquila, Rozzano, Naples, Rome, Bologna, Brescia, Catania
2023-10-11
Active, closed
AbbVie
Phase 3
1,328
Cona, Florence, L’Aquila, Rome, Brescia, Milan, Modena, Pisa
2023-06-21
Recruiting
Automated Fetal Cardiac Function in Babies Affected by Heart Diseases
NCT05698277Congenital Heart Defect, Cardiac Function
Anna Erenbourg
Observational
495
L’Aquila, Milan, Trieste
2023-05-01
By invitation
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Observational
1,000
L’Aquila
2023-04-01
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Brescia, Cremona, Foligno, Genova, Gubbio, Lecce, Lecco, L’Aquila
2023-02-15
Recruiting
Iperboreal Pharma Srl
Phase 3
170
Ascoli Piceno, Bagno a Ripoli, Bari, Brescia, Chieti, Genova, L’Aquila, Milan
2022-12-14
Active, closed
Galderma R&D
Phase 3
500
Catania, Chieti, Genova, L’Aquila, Modena, Naples, Parma, Perugia
2021-01-11
Active, closed
Galderma R&D
Phase 3
1,700
Bologna, L’Aquila, Roma, Rome, Rozzano, Vicenza
2019-12-30
Active, closed
Sanofi
Observational
955
Torrette Di Ancona, Terracina, Rome, Bari, Brescia, Cagliari, Genova, L’Aquila
2019-06-11
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Bergamo, Bologna, Brescia, Florence, L’Aquila, Milan, Naples, Rome
2019-06-04
Active, closed
Università degli Studi dell'Aquila
Phase 4
80
L’Aquila
2019-05-01
Rows per page Showing 1–33 of 33
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-italy/city/l-aquila

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 33 of those studies with a site in L’Aquila.

How many clinical trials are recruiting in L’Aquila?

16 of the 33 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 12 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (L’Aquila), 33 studies
PhaseStudiesRecruitingShare
Phase 316748.5%
Observational10430.3%
Not applicable5415.2%
Phase 2113%
Phase 4103%

Most active sponsors

Lead sponsors with the most studies (L’Aquila)
Lead sponsorStudiesRecruiting
University of L'Aquila52
AbbVie43
Galderma R&D20
Incyte Corporation21
Pfizer20
Sanofi20
Alnylam Pharmaceuticals11
Amgen11
Anna Erenbourg11
Bristol-Myers Squibb11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.